EQ

Equillium (EQ)

Equillium Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EQ

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	05:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EQ	Equillium Inc
2024/05/10	05:01	Business Wire	Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights	NASDAQ:EQ	Equillium Inc
2024/05/07	21:00	Business Wire	Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists	NASDAQ:EQ	Equillium Inc
2024/04/03	21:00	Business Wire	Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EQ	Equillium Inc
2024/04/01	21:00	Business Wire	Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis	NASDAQ:EQ	Equillium Inc
2024/03/26	05:01	Business Wire	Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights	NASDAQ:EQ	Equillium Inc
2024/03/22	21:00	Business Wire	Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference	NASDAQ:EQ	Equillium Inc
2024/03/09	07:35	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:EQ	Equillium Inc
2024/03/09	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2024/02/24	07:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2024/02/24	07:09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:EQ	Equillium Inc
2024/02/22	20:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2024/01/04	08:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQ	Equillium Inc
2024/01/04	08:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQ	Equillium Inc
2024/01/04	08:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQ	Equillium Inc
2023/12/21	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2023/12/21	22:00	Business Wire	Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease	NASDAQ:EQ	Equillium Inc
2023/11/21	01:23	PR Newswire (US)	EQ Bank Card launches in Québec as Carte Banque EQ	NASDAQ:EQ	Equillium Inc
2023/11/21	01:23	PR Newswire (Canada)	EQ Bank Card launches in Québec as Carte Banque EQ	NASDAQ:EQ	Equillium Inc
2023/11/13	23:00	Business Wire	Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology	NASDAQ:EQ	Equillium Inc
2023/11/09	06:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EQ	Equillium Inc
2023/11/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2023/11/09	06:01	Business Wire	Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates	NASDAQ:EQ	Equillium Inc
2023/11/06	22:00	Business Wire	Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology	NASDAQ:EQ	Equillium Inc
2023/10/19	21:00	Business Wire	Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology	NASDAQ:EQ	Equillium Inc
2023/10/16	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2023/10/16	21:00	Business Wire	Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium	NASDAQ:EQ	Equillium Inc
2023/10/06	06:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2023/10/06	06:23	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:EQ	Equillium Inc
2023/10/03	21:00	Business Wire	Equillium to Host Analyst & Investor Day	NASDAQ:EQ	Equillium Inc